View in: PubMed Mentions: 19 Fields: Translation:HumansPHPublic Health Fast food, central nervous system insulin resistance, and obesity
Pregnancy and breastfeeding GLP-1 receptor agonists are generally not recommended during pregnancy or breastfeeding
Are the NEFA that activate GPR 120 receptors the same ones that stimulate GLP-1 secretion, e.g
High-purity GLP-1 analog, 99% COA verified
In clinical trials conducted by Novo Nordisk, participants who were administered semi-weekly doses of Wegovy lost an average of approximately 15% of their body weight over a period ranging from 68 weeks to more than two years
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
